Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
08 March, 2021 11:55 IST
IDBI Capital reiterates Accumulate rating on DCB Bank
Source: IRIS | 25 Jan, 2021, 01.57PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

 DCB Bank's loan growth on the overall book came at -0.5% versus 0.3% YoY while growth ex-corporate segment stood at 0.6% YoY. Its core segment Mortgage has grown by 2% while SME segment declined by 0.5% YoY due to cautious approach. AIB book declined by 0.5% YoY; however Corporate segment continuous to de-grow (down 8.8%YoY). Overall, Bank will head up the sales by Mar-April and increase headcounts in Mortgages and Home loans while expects to grow at double digit in FY22. Deposits declined by 3% YoY led by declined in inter-bank term deposits.

Bank's asset quality deteriorated- Restructuring book at 3%- Net restructured book stood at Rs 6.87 billion (2.7% of advances) largely from Mortgages, CV and SME/MSME while guided for 3-5% of book. Bank Proforma GNPA worsens to 3.70% vs 2.39% QoQ and NNPA at 1.92% vs 0.83% QoQ. Gross slippages (Proforma) stood at Rs 4.48 billion and holds provisions of Rs 1.14 billion (25%) against that. Apart from this bank hold provisions of Rs 5.19 billion (2.05% of advances) which provides cushion on P&L. We need to watch out for slippages from restructured book, said IDBI Capital.

Margins remain stable at 3.75 (3.74% QoQ) as decline in cost of funds was compensated by decline in yields (led by interest reversal). Cost to income ratio continues to decline from highs of 57% in FY19 to 43% in Q3FY21 as operating expenses declined 6% YoY.

Commenting on the result review, the broking firm IDBI Capital said, "DCB Bank's asset quality worsens as Proforma GNPA stood at 3.70% versus 2.39% (Q2FY21) and NNPA at 1.92% versus 0.83% QoQ. Net restructured book stands at Rs 6.87 billion (2.7% of advances) while company expects 3%-5% of book to get restructure. Bank’s credit and deposit growth Continues to slow down at -0.5% (0.3% in Q2FY21) and -2.9% (-2% in Q2FY21) respectively. NII grew by 3.6% YoY while PAT de-grew by 0.5% YoY led by higher provisions (up 150% YoY; Rs.2.29 billion for Covid-19 provisions)."

"Cost-to-income ratio on a QoQ basis has declined by 1106bps to 43.3% sequentially. Bank reported collection efficiency for key portfolios (Dec’20) - LAP/Home loans/CV loans at 89.8%/94.1%/80.4% versus 87.5%/91.3%/ 77.1% (Sep’20) respectively.

However, Customer paid 3 EMI or more in LAP/Home loans/CV loans stands at 92.9%/93.3%/ 86.5% respectively.

IDBI Capital re-iterates its rating to 'Accumulate' with new TP of Rs.125 (earlier Rs.88) valuing it at 0.9x (earlier 0.7x) P/ABV FY23 as revival in the economy is better than expected.

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.


 Post Comment
Name Email
Security Code type    into this box
Rushil Decor rallies on starting regular commercial production at Andhra Pradesh Unit - 08-Mar-2021 12:43
AGEL commissions 100 MW Gujarat Wind Power Project 5 months before schedule - 08-Mar-2021 12:30
NMDC surges on fixing iron ore prices - 08-Mar-2021 12:19
Meera Industries jumps on winning export order worth USD 180,000 - 08-Mar-2021 12:03
Jagran Prakashan plans to buyback shares worth Rs 1,180 mn - 08-Mar-2021 09:27
Kotak Mahindra Bank divests 10% stake in ECA Trading Services to its arm - 08-Mar-2021 09:07
Hero MotoCorp February sales crosses 5 lakh units - 05-Mar-2021 17:57
PVR launches new six-screen property in Mysuru - 05-Mar-2021 16:55
Voltas strong performance raises expectations of blockbuster summer sales: Motilal Oswal - 05-Mar-2021 13:27
Unichem Lab gets USFDA nod for Guanfacine Tablets - 05-Mar-2021 13:03
Buy Gland Pharma; target price of Rs 2,700: Motilal Oswal - 05-Mar-2021 12:54
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer